Is Denali Therapeutics Inc. (DNLI) a Buy, Sell, or Hold?
NASDAQ : DNLI
Denali Therapeutics Inc. — Competitors
$23.02 USD
-$1.33 (-5.46%)
- Volume
- 1.23M
- Average Volume
- 1.9M
- Market Capitalization
- $3.65B
- P/E Ratio
- -7.99
- Dividend Yield
- 0.00%
- Price Target
- $36.00
- Year High
- $27.30
- Year Low
- $12.58
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.28
DNLI vs. The Competition
| Properties | DNLI | AGIO | BEAM | COGT |
|---|---|---|---|---|
| Market Cap | $3.65B | $1.79B | $2.63B | $6.65B |
| Shares Outstanding | $158.71M | $59.7M | $102.88M | $170.87M |
| P/E Ratio | -7.99 | -4.28 | -39.87 | -12.64 |
| EPS | -2.72 | -6.91 | -0.63 | -5.26 |
| Day Low | 22.99 | 29.97 | 25.3563 | 38.755 |
| Day High | 24.35 | 33.34 | 26.933 | 41.305 |
| Year Low | 12.58 | 22.24 | 15.6 | 10.38 |
| Year High | 27.3 | 46 | 38.26 | 43.73 |
| Average Price 50 | 22.898 | 34.1918 | 30.7294 | 36.5047 |
| Average Price 200 | 19.83763 | 31.6259 | 28.10195 | 34.7368 |
| Volume | 1.23M | 2.1M | 1.07M | 1.55M |
| Average Volume | - | - | - | - |